SCIENCE IN THE NEWS DAILY
Vaccine Doubles Brain Cancer Survival Time
from the Guardian (UK)
A vaccine that more than doubles the survival time of patients with the most common and aggressive form of brain cancer has been developed by scientists.
Early results from clinical trials suggest patients who received the vaccine lived for nearly three years after being diagnosed with glioblastoma multiforme.
Patients given traditional anti-cancer treatment, including a combination of surgery, chemotherapy and radiotherapy, typically survived for a little more than a year following diagnosis. John Sampson, a neurosurgeon at Duke University's brain tumour centre in North Carolina, who led the trial, said: "We're more than doubling the survival time in this group, and we have some patients who are four, five or six years out from diagnosis, which is virtually unheard of in these people."
Read more ...
Connect With Us:
PODCASTS: Expanding With the Cosmos
Using the Atacama Cosmology Telescope (ATC), a 6.5-meter microwave collector in Chile, cosmologists are piecing together the early history of the known universe. In an exclusive American Scientist interview, Arthur Kosowsky—a member of the ATC team and a professor in the Department of Physics and Astronomy at the University of Pittsburgh—discusses how he is using ATC to reach back in time billions of years to search for gravitational waves that could verify inflation and reveal unprecedented details about how the cosmos was born.
To view all multimedia content, click "Latest Multimedia."
Receive notification when new content is posted from the entire website, or choose from the customized feeds available.